The microbiology laboratory's role in life-threatening infections

Critical Care Nursing Quarterly

Volumn 20, Issue 3, 1997, Pages 44-59

  Papasian, Christopher J ^a   Kragel, Peter J ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antimicrobial suseptihibility testing; Diagnosis; Laboratory; Life threatening infections; Microbiology; Specimen collection

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFAZOLIN; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; NAFCILLIN; NITROFURANTOIN; NORFLOXACIN; PENICILLIN G; PIPERACILLIN; TIMENTIN; TOBRAMYCIN; VANCOMYCIN;

BACTEREMIA; BLOOD CULTURE; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID ANALYSIS; CRITICAL ILLNESS; DRUG SENSITIVITY; GRAM NEGATIVE BACTERIUM; GRAM STAINING; HUMAN; INFECTION; LABORATORY TEST; MICROBIOLOGY; MINIMUM INHIBITORY CONCENTRATION; PNEUMONIA; REVIEW; SKIN INFECTION; SOFT TISSUE INFECTION; SPUTUM CULTURE; URINARY TRACT INFECTION; URINE CULTURE;

EID: 0030689023     PISSN: 08879303     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002727-199711000-00006     Document Type: Review

References (47)

1. Stevens DL. Invasive Group A Streptococcus infections. Clin Infect Dis. 1992;14:2-13.
2. Forni AL, Kaplan EL, Schlievert PM, Roberts RB. Clinical and microbiological characteristics of severe Group A Streptococcus infections and streptococcal toxic shock syndrome. Clin Infect Dis. 1995;21:333-340.
3. American Thoracic Society. Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis. 1990;142:725-735.
4. Pfaller MA. Application of new technology to the detection, identification and antimicrobial susceptibility testing of mycobacteria. Am J Clin Pathol. 1994;101:329-337.
5. Tenover FC, Crawford JT, Huebner RE, Geiter LJ, Horsburgh CR Jr, Good RC. The resurgence of tuberculosis: is your laboratory ready? J Clin Microbiol. 1993;31:767-770.
6. Doern GV, Vautour R, Gaudet M, Levy B. Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J Clin Microbiol. 1994;32:1757-1762.
7. Edwards LD, Levin S, Balagtas R, Lowe P, Laundau W, Lepper MH. Ordering patterns and utilization of bacteriologic culture reports. Arch Intern Med. 1973;132:678-682.
8. Koontz FP. Clinician utilization of rapid antibiotic susceptibility data - a prospective study. J Assoc Rapid Methods Automat Microbiol. 1991;4:69-75.
9. Roark MK, Reed WE Jr. Econotherapeutics. Diagn Microbiol Infect Dis. 1995;22:209-217.
10. Hess DA, Mahoney CD, Johnson PN, Corrao WM, Fisher AE. Integration of clinical and administrative strategies to reduce expenditures for antimicrobial agents. Am J Hosp Pharm. 1990;47:585-591.
11. Jarvis WR, Marione WJ. Predominant pathogens in hospital infections. J Antimicrob Chemother. 1992;29(suppl A):19-24.
12. Sanders CC, Thomson KS, Bradford PA. Problems with detection of beta-lactam resistance among nonfastidious gram-negative bacilli. Infect Dis Clin North Am. 1993;7:411-424.
13. Weinstein JW, Roe M, Towns M, et al. Resistant enterococci: a prospective study of prevalence, incidence, and factors associated with colonization in a university hospital. Infect Cont Hosp Epidemiol. 1996;17:36-41.
14. Murray BE. What can we do about vancomycin-resistant enterococci. Clin Infect Dis. 1995;20:1134-1136.
15. Doebbeling BN. The epidemiology of methicillin-resistant Staphylococcus aureus colonization and infection. J Chemother. 1995;7 (suppl 3):99-103.
16. Pujol M, Pena C, Pallares R, Ayats J, Ariza J, Gudiol F. Risk factors for nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis. 1994;13:96-102.
17. Bartlett JG. Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism. Clin Infect Dis. 1994;18 (suppl 4):S265-S272.
18. Edmond MB, Wenzel RP, Pasculle AW. Vancomycin-resistant Staphylococcus aureus: perspectives on measures needed for control. Ann Intern Med. 1996;124:329-334.
19. Jorgensen JH. Antimicrobial susceptibility testing of bacteria that grow aerobically. Infect Dis Clin North Am. 1993;7:393-409.
20. Rosenblatt JE. Laboratory tests used to guide antimicrobial therapy. Mayo Clin Proc. 1991;66:942-948.
21. Stratton CW IV, Ratner H, Johnston PE, Schaffner W. Focused microbiologic surveillance by specific hospital unit: practical application and clinical utility. Clin Ther. 1993;15 (suppl A):12-20.
22. Murray PR, Washington JA II. Microscopic and bacteriologic analysis of expectorated sputum. Mayo Clin Proc. 1975;50:339-344.
23. Van Scoy RE. Bacterial sputum cultures: a clinican's viewpoint. Mayo Clin Proc. 1977;52:39-41.
24. Baselski VS, El-Torky M, Coalson JJ, Griffin JP. The standardization of criteria for processing and interpreting laboratory specimens in patients with suspected ventilator-associated pneumonia. Chest. 1992;102:5 71S-579S.
25. Morris AJ, Tanner DC, Reller LB. Rejection criteria for endotracheal aspirates from adults. J Clin Microbiol. 1993;31:1027-1029.
26. Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med. 1993;329:1328-1334.
27. Fisher JF, Newman CL, Sobel JD. Yeast in the urine: solutions for a budding problem. Clin Infect Dis. 1995; 20:183-189.
28. Sodeman TM. A practical strategy for diagnosis of urinary tract infections. Clin Lab Med. 1995;15:235-250.
29. Weinstein MP. Current blood culture methods and systems: clinical concepts, technology, and interpretation of results. Clin Infect Dis. 1996;23:40-46.
30. Washington JA II, Ilstrup DM. Blood cultures: issues and controversies. Rev Infect Dis. 1986;8:792-802.
31. Bates DW, Goldman L, Lee TH. Contaminant blood cultures and resource utilization. JAMA. 1991;265:365-369.
32. Tonnesen A, Peuler M, Lockwood WR. Cultures of blood drawn by catheters vs venipuncture. JAMA. 1976; 235:1877.
33. Papasian CJ, Parker JC Jr. Bacterial and fungal infections. In: Duckett S, ed. Pediatric Neuropathology. Malvern, Pa: Williams & Wilkins; 1995:353-373.
34. Gray LD, Fedorko DP. Laboratory diagnosis of bacterial meningitis. Clin Microbiol Rev. 1992;5:130-145.
35. Albrecht WE, Papasian CJ, Bamberger DM, Fiorella R, Riddell SW. Infected abdominal aortic aneurysm due to penicillin, ceftriaxone, and cefotaxime-resistant Streptococcus pneumoniae. J Clin Microbiol. 1997;35:985-987.
36. Drew WL. Controversies in viral diagnosis. Rev Infect Dis. 1986;8:814-824.
37. Chonmaitree T, Menegus MA, Powell KR. The clinical relevance of "CSF viral culture." A two year experience with aseptic meningitis in Rochester, N.Y. JAMA. 1982;247:1843-1847.
38. Rozenberg F, Lebon P. Amplification and characterization of herpesvirus DNA in cerebrospinal fluid from patients with acute encephalitis. J Clin Microbiol. 1991;29:2412-2417.
39. Chun CH, Johnson JD, Hofstetter M, Raff MJ. Brain abscess: a study of 45 consecutive cases. Medicine. 1986;65:415-431.
40. George R, Leibrock L, Epstein M. Long term analysis of cerebrospinal fluid shunt infections. A 25 year experience. J Neurosurg. 1979;51:804-811.
41. Hook EW III, Hooton TM, Horton CA, Coyle MB, Ramsey PG, Turck M. Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med. 1986;146:295-297.
42. Brook I, Frazier EH. Aerobic and anaerobic bacteriology of wounds and cutaneous abscesses. Arch Surg. 1990;125:1445-1451.
43. Wheat LJ, Allen SD, Henry M, et al. Diabetic foot infections. Bacteriologic analysis. Arch Intern Med. 1986;146:1935-1940.
44. Allman RM. Pressure ulcers among the elderly. N Engl J Med. 1989;320:850-853.
45. Rudensky B, Lipschits M, Isaacsohn M, Sonnenblick M. Infected pressure sores: comparison of methods for bacterial identification. South Med J. 1992;85:901-903.
46. Washington JA II. The microbiology of musculoskeletal infection. Orthop. Clin North Am. 1975;6:1115-1128.
47. Monson TP, Nelson CL. Microbiology for orthopaedic surgeons: selected aspects. Clin Orthop. 1984;190:14-22.